Superbugs Pose Deadly Threat: Experts Warn Drug Pipeline Is Dangerously Thin
Experts warn the pipeline of new drugs to fight antibiotic-resistant superbugs has shrunk by 35% in 5 years, predicting a doubling in deaths by 2050 if action isn't taken.
Superbugs, or bacteria that have become resistant to most or all antibiotics, pose a grave threat to global health. Experts are sounding the alarm as the pipeline of new drugs to combat these deadly infections has dwindled alarmingly in recent years.
According to a new report from the Access to Medicine Foundation (AMF) and the Wellcome Trust, the number of antibiotic development projects from major pharmaceutical companies has dropped by 35% over the past five years, from 92 down to just 60 medicines in development.
This shrinking pipeline is especially concerning given predictions that the annual number of deaths linked to drug-resistant infections could double to 8 million globally by 2050 if urgent action is not taken.
{{IMAGE_PLACEHOLDER}}Source: The Guardian
